MCAZ registers each medicine before import, and every consignment then needs its own import permit.

MCAZ registers the product before anyone can import or sell it

The Medicines Control Authority of Zimbabwe (MCAZ) is the national regulator for human and veterinary medicines, medical devices and allied substances. Its Evaluations and Registrations division reviews the safety, quality and efficacy of a product before it can be marketed, sold or distributed anywhere in the country.

An application goes in on the statutory MC-8 form, with a supporting dossier in CTD format (Modules 1 to 5 for conventional medicines). MCAZ screens the submission for completeness first: an incomplete file is returned, and a second failed screening leads to refusal without a full assessment. A complete application then goes through evaluation, typically resolved within one or two review cycles under MCAZ's own clock-start, clock-stop system. Fees are quoted and paid through the ZIMDIS portal before the file is accepted.

Once a certificate is granted, it is not permanent. MCAZ charges an annual retention fee on every registration, due each 1 April, to keep the product on the register. A lapsed retention effectively removes the product from the approved list, which is worth building into any long-term supply plan for the market.

M Care Exports prepares the CTD dossier for each molecule against MCAZ's own submission guidelines rather than a generic template. Our CTD dossier preparation service covers Module 3 quality data, stability data and the site master file references MCAZ screens for on first pass.

Only specific licence holders may import a registered medicine

MCAZ restricts who can bring medicines into Zimbabwe. The core route is a wholesale dealer's permit holder who has been formally appointed as the authorised importer or exporter by the principal (the manufacturer or brand owner) for that specific product. Licensed pharmacies, licensed manufacturers, and medical, dental or veterinary practitioners holding a dispensing licence can also import within their own scope of practice, alongside any other party MCAZ specifically approves.

For an Indian exporter this means the buyer's licence status has to be confirmed before a shipment is planned, not after it lands. M Care Exports asks a new Zimbabwean buyer for their current wholesale dealer's permit and, where the goods are proprietary, a letter of authorisation naming that buyer as an appointed importer for the product.

Two documentation gaps recur in practice:

• A wholesale permit that has lapsed or is under renewal at the point of shipment.
• No written appointment letter from the principal, which MCAZ's screening checklist looks for on branded product applications.

Confirming both before goods leave India avoids a consignment sitting at the port while paperwork catches up.

Every consignment needs its own import permit, arranged before dispatch

Registration approves the product; it does not clear a shipment. MCAZ requires a separate import permit application for each consignment, submitted on the official form with the quantity, the name and address of the supplier and manufacturer, the Zimbabwean registration reference, and the Cost, Insurance and Freight (CIF) value. Applications go to MCAZ's Harare office, with an electronic copy to its imports mailbox.

Authorisation has to be in hand before the consignment leaves the country of origin, not requested once it reaches the border. On arrival, MCAZ officers physically verify the shipment at a designated port of entry, and a verification fee of 0.05% of the CIF value is payable before the goods can be cleared for sale. Where cold-chain products are involved, MCAZ asks importers to notify customs in advance so the consignment moves straight to approved storage.

For an unregistered medicine brought in under a documented public-health need, a separate authorisation applies (a Section 75 application), which carries its own retainer fee and is handled case by case rather than through the standard permit route.

Because the permit is tied to CIF value and exact consignment detail, M Care Exports finalises the commercial invoice and packing list before the buyer files with MCAZ, so the figures the buyer submits match what actually ships.

NatPharm buys and distributes for the public health sector

NatPharm (the National Pharmaceuticals Company) is Zimbabwe's state-owned central medical store, established by an Act of Parliament in 2001. Its mandate is to procure, store and distribute medicines and medical supplies to public health institutions, and it runs depots in Harare, Bulawayo, Chinhoyi, Gweru, Masvingo and Mutare to do it.

NatPharm sits downstream of MCAZ, not alongside it: it buys registered products, it does not register them. A supplier still needs MCAZ product registration and a licensed Zimbabwean importer of record in place before NatPharm can procure against a tender, since public-sector procurement in Zimbabwe requires goods to be registered and legally imported as a condition of any award.

For an Indian exporter targeting public-sector volume in Zimbabwe, the practical sequence is registration first, a compliant local importer partner second, and only then a NatPharm tender submission. Buyers comparing this to other single-desk public procurers in the region can see how the same pattern plays out in Kenya's KEMSA and PPB structure.

ZAZIBONA can shorten the route to registration in Zimbabwe

MCAZ is a founding member of ZAZIBONA, the SADC collaborative medicines registration procedure that began in 2013 with Zambia, Zimbabwe, Botswana and Namibia and now has nine active member authorities including South Africa, Mozambique, Malawi and Tanzania. Under ZAZIBONA, participating regulators jointly assess a single CTD-format dossier, with MCAZ acting as rapporteur (lead assessor) or co-rapporteur (peer reviewer) depending on the product.

To use the route, an application has to be lodged in CTD format with at least two ZAZIBONA participating countries at the same time. That makes it most useful where a supplier is registering the same molecule in Zimbabwe and a neighbouring SADC market together, rather than a Zimbabwe-only filing.

ZAZIBONA is a work-sharing mechanism between national regulators, distinct from WHO prequalification or a stringent-authority reliance route. For a fuller comparison of what each reliance pathway actually saves in time and evidence, see WHO prequalification versus national registration.

What the Indian exporter needs to have ready

MCAZ's dossier and permit screening both trace back to documents that originate on the Indian side. M Care Exports assembles this pack per molecule before a Zimbabwean buyer files anything:

1. Certificate of Pharmaceutical Product (CoPP) in WHO format, issued by India's licensing authority for the manufacturing site.
2. Manufacturing site GMP certificate, current and matched to the exact product and dosage form.
3. Free Sale Certificate confirming the product is marketed or approved in the country of manufacture.
4. Certificate of Analysis for the specific batch, from the manufacturing site's own laboratory.
5. CTD dossier (Module 3 quality data, stability data, and the pharmacovigilance and labelling sections MCAZ expects in Modules 1 and 2).
6. Commercial invoice, packing list and certificate of origin, with values that reconcile exactly to what the Zimbabwean importer declares on the MCAZ permit application.

M Care Exports is a merchant-exporter, not a manufacturer: we source both originator brands through licensed Indian channels and generics from WHO-GMP certified manufacturing partners, and we compile the paperwork from the actual manufacturing site rather than a generic template. A buyer with a specific molecule in mind can start that conversation through Request a Medicine or set up ongoing supply through a trade account.

Frequently asked

Does MCAZ require product registration before medicines can be imported into Zimbabwe?

Yes. MCAZ's Evaluations and Registrations division has to approve a medicine before it can be marketed, sold or distributed in Zimbabwe. Registration is based on an MC-8 application and a CTD-format dossier covering quality, safety and efficacy data, screened for completeness before it goes to full evaluation. A registration certificate then needs an annual retention fee to stay valid, due each 1 April. Import permits, which cover individual shipments, are a separate step that comes after registration, not instead of it.

Who is allowed to import registered medicines into Zimbabwe?

A holder of an MCAZ wholesale dealer's permit who has been formally appointed as the authorised importer by the product's principal is the main route. Licensed pharmacies, licensed manufacturers, and medical, dental or veterinary practitioners with a dispensing licence can also import within their own scope, along with any other party MCAZ specifically approves. An Indian supplier should confirm a Zimbabwean buyer's current wholesale permit, and for branded products a written appointment letter, before agreeing a shipment schedule.

Is an import permit needed for every consignment, or just once per product?

Every consignment needs its own import permit. Registration approves the product itself; the permit authorises that specific shipment, based on its quantity, supplier and manufacturer details, the Zimbabwean registration reference, and the CIF value. Authorisation must be granted before the goods leave the country of origin. On arrival, MCAZ officers verify the consignment at a designated port of entry, and a verification fee of 0.05% of CIF value is payable before the goods clear for sale.

What is NatPharm, and does it register or just buy medicines?

NatPharm (the National Pharmaceuticals Company) is Zimbabwe's state-owned central medical store, set up by an Act of Parliament in 2001 to procure, store and distribute medicines and medical supplies to public health institutions from depots across the country. It is a buyer, not a regulator: NatPharm procures products that are already MCAZ-registered and imported through a licensed importer. A supplier targeting NatPharm tenders needs MCAZ registration and a compliant local importer in place first.

What is ZAZIBONA and does it speed up MCAZ registration?

ZAZIBONA is a SADC collaborative medicines registration procedure that MCAZ helped found, alongside regulators from Zambia, Botswana, Namibia, South Africa and several other member states. Participating authorities jointly assess a single CTD dossier, with MCAZ acting as lead or peer reviewer. To use it, the same application has to be filed in at least two ZAZIBONA countries at once, so it suits a supplier registering a molecule across Zimbabwe and a neighbouring SADC market together, rather than a Zimbabwe-only filing.

What documents does M Care Exports provide to support an MCAZ import permit application?

For each molecule, M Care Exports prepares a Certificate of Pharmaceutical Product in WHO format, a current manufacturing site GMP certificate, a Free Sale Certificate, a batch Certificate of Analysis, and the CTD dossier modules MCAZ's screening checklist looks for. Commercial invoice, packing list and certificate of origin are finalised against the exact figures the Zimbabwean buyer will declare on the MCAZ permit application, so the paperwork on both sides matches when the consignment is verified at the port.